A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain

Neuropathic pain (NeP) is generally considered an intractable problem, which becomes compelling in clinical practice when caused by highly effective chemotherapeutics, such as in the treatment of cancer with oxaliplatin (OXA) and related drugs. In the present work we describe a structurally new comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nativi, Cristina, Gualdani, Roberta, Dragoni, Elisa, Di Cesare Mannelli, Lorenzo, Sostegni, Silvia, Norcini, Martina, Gabrielli, Gabriele, la Marca, Giancarlo, Richichi, Barbara, Francesconi, Oscar, Moncelli, Maria Rosa, Ghelardini, Carla, Roelens, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684817/
https://www.ncbi.nlm.nih.gov/pubmed/23774285
http://dx.doi.org/10.1038/srep02005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684817/
https://www.ncbi.nlm.nih.gov/pubmed/23774285
http://dx.doi.org/10.1038/srep02005

Ejemplares similares